Academic Journal

Multiple Myeloma DREAM Challenge reveals epigenetic regulator PHF19 as marker of aggressive disease

Bibliographic Details
Title: Multiple Myeloma DREAM Challenge reveals epigenetic regulator PHF19 as marker of aggressive disease
Authors: Hongjie Chen, Yuanfang Guan, Nikhil C. Munshi, Samuel A. Danziger, Andrew Dervan, Bailiang Li, Aditya Pratapa, Christine Eng, Matthew Trotter, Hervé Avet-Loiseau, Justin Guinney, Erin Flynt, Dan Rozelle, Maria Ortiz, Douglas Bassett, Michael Mason, Alexander V. Ratushny, Carolina Schinke, Thomas Yu, Kenneth H. Shain, Fred K. Gruber, Elias Chaibub Neto, Boris Hayete, Hongyue Y Dai, Jonathan Göke, Fadi Towfic, Dirk Hose, Pieter Sonneveld, Anjan Thakurta, Daniel Auclair, Valeriy V. Lyzogubov, Gareth J. Morgan, Mehmet Kemal Samur, Brian A Walker, Konstantinos Mavrommatis, Hartmut Goldschmidt, Brian S. White, William S. Dalton, Kamlesh Bisht, Yi Cui, Frank Schmitz
Contributors: Computer Science, Basic (bio-) Medical Sciences
Source: Leukemia
Leukemia 34, 1866–1874 (2020)
Publication Status: Preprint
Publisher Information: Springer Science and Business Media LLC, 2019.
Publication Year: 2019
Subject Terms: 0301 basic medicine, Clinical Trials as Topic/statistics & numerical data, Databases, Factual, Transcription Factors/genetics, Datasets as Topic, Multiple Myeloma/genetics, Article, Epigenesis, Genetic, 03 medical and health sciences, Biomarkers, Tumor, Tumor Cells, Cultured, Humans, Cell Proliferation, Clinical Trials as Topic, 0303 health sciences, Models, Statistical, Cell Cycle, 3. Good health, DNA-Binding Proteins, Gene Expression Regulation, Neoplastic, cell proliferation, cell cycle, Biomarkers, Tumor/genetics, Multiple Myeloma, DNA-Binding Proteins/genetics, Transcription Factors
Description: While the past decade has seen meaningful improvements in clinical outcomes for multiple myeloma patients, a subset of patients does not benefit from current therapeutics for unclear reasons. Many gene expression-based models of risk have been developed, but each model uses a different combination of genes and often involves assaying many genes making them difficult to implement. We organized the Multiple Myeloma DREAM Challenge, a crowdsourced effort to develop models of rapid progression in newly diagnosed myeloma patients and to benchmark these against previously published models. This effort lead to more robust predictors and found that incorporating specific demographic and clinical features improved gene expression-based models of high risk. Furthermore, post-challenge analysis identified a novel expression-based risk marker, PHF19, which has recently been found to have an important biological role in multiple myeloma. Lastly, we show that a simple four feature predictor composed of age, ISS, and expression of PHF19 and MMSET performs similarly to more complex models with many more gene expression features included.
Document Type: Article
Other literature type
File Description: application/pdf
Language: English
ISSN: 1476-5551
0887-6924
DOI: 10.1038/s41375-020-0742-z
DOI: 10.1101/737122
Access URL: https://www.nature.com/articles/s41375-020-0742-z.pdf
https://pubmed.ncbi.nlm.nih.gov/32060406
https://www.nature.com/articles/s41375-020-0742-z
https://research.monash.edu/en/publications/multiple-myeloma-dream-challenge-reveals-epigenetic-regulator-phf
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326699
https://pubmed.ncbi.nlm.nih.gov/32060406/
https://www.nature.com/articles/s41375-020-0742-z.pdf
https://www.biorxiv.org/content/10.1101/737122v1
https://www.biorxiv.org/content/biorxiv/early/2019/08/22/737122.full.pdf
http://hdl.handle.net/10919/101772
https://doi.org/10.1038/s41375-020-0742-z
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=59519
https://biblio.vub.ac.be/vubir/multiple-myeloma-dream-challenge-reveals-epigenetic-regulator-phf19-as-marker-of-aggressive-disease(442b1410-5b74-496c-8eff-4da366b7d420).html
Rights: CC BY
Accession Number: edsair.doi.dedup.....c95c98ba8ff90bd994e2b93c3b359762
Database: OpenAIRE
Description
ISSN:14765551
08876924
DOI:10.1038/s41375-020-0742-z